Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
Abstract Introduction Atogepant is a calcitonin gene-related peptide receptor antagonist approved for the preventive treatment of migraine in adults in the USA, EU, and several other countries. The objectives of this study were to evaluate the pharmacokinetics (PK) and dose proportionality of atogep...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Adis, Springer Healthcare
2025-01-01
|
| Series: | Neurology and Therapy |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s40120-024-00699-2 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
